发明名称 Methods of evaluating patients using E-cadherin and vimentin
摘要 Methods for the selection, evaluation, and/or treatment of a patient having cancer with an inhibitor of a glutamine-utilizing enzyme or a glutamine-depleting agent, by evaluating E-cadherin or vimentin expression are disclosed.
申请公布号 US9618514(B2) 申请公布日期 2017.04.11
申请号 US201314428456 申请日期 2013.09.16
申请人 AGIOS PHARMACEUTICALS, INC 发明人 Choe Sung Eun;Hurov Jonathan;Ulanet Danielle
分类号 C12Q1/68;G01N33/574;A61K38/50;A61K31/433 主分类号 C12Q1/68
代理机构 Lando & Anastasi, LLP 代理人 Lando & Anastasi, LLP
主权项 1. A method of treating a patient having cancer, the method comprising: acquiring an evaluation of or evaluating a patient sample, wherein the sample is evaluated for i) E-cadherin expression levels and ii) vimentin expression levels; and if E-cadherin expression levels are low, and vimentin expression levels are high, as compared to a reference standard, then administering to the patient in need thereof a therapeutically effective amount of an inhibitor of a glutamine-utilizing enzyme or a glutamine-depleting agent.
地址 Cambridge MA US